Close Menu
Home › Trinity Biotech Posts Flat Q4 Revenues

Trinity Biotech Posts Flat Q4 Revenues

Mar 07, 2019

NEW YORK (360Dx) — Irish diagnostics firm Trinity Biotech reported today revenues of $24.6 million for the fourth quarter of 2018, essentially unchanged from the same period a year earlier amid a drop in revenues from its clinical laboratory operations.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
27
Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Apr
30
Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

What's Popular?

In Point-of-Care Testing

  1. Blood-Based PTSD Diagnostic Being Developed by Indiana University Team

    Premium

  2. Roche Files Lawsuit Alleging Insurance Fraud Over Diabetes Test Strips

  3. GenePOC Strep A Test Granted FDA Clearance

  4. Smartphone-Based Breath Diagnostic Targets Gastric Cancer Screening

    Premium

  5. Glaucoma Diagnostic Targeted by Mannin Research, McMaster University Collaboration

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.